Stefan Stremitzer
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Co-authors
- Thomas Gruenberger (20 shared papers)Michael Bergmann (6 shared papers)Dietmar Tamandl (11 shared papers)Judith Stift (15 shared papers)Thomas Hoelzenbein (3 shared papers)Heinz‐Josef Lenz (26 shared papers)Sebastian Stintzing (26 shared papers)Martina Mittlboeck (2 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)The Pharmacogenomics Journal (7 papers)European Journal of Surgical Oncology (6 papers)Annals of Oncology (4 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- AustriaUnited StatesJapan
In The Last Decade
Stefan Stremitzer
73 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Hepatology 289
- Oncology 563
- Occupational Therapy 55
- Rehabilitation 75
- Cancer Research 156
Countries citing papers authored by Stefan Stremitzer
This map shows the geographic impact of Stefan Stremitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Stremitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Stremitzer more than expected).
Fields of papers citing papers by Stefan Stremitzer
This network shows the impact of papers produced by Stefan Stremitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Stremitzer. The network helps show where Stefan Stremitzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Stremitzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 104 | |
| 2 | 2014 | 84 | |
| 3 | 2012 | 58 | |
| 4 | 2018 | 53 | |
| 5 | 2007 | 48 | |
| 6 | 2002 | 47 | |
| 7 | 2019 | 47 | |
| 8 | 2015 | 41 | |
| 9 | 2011 | 37 | |
| 10 | 2016 | 36 | |
| 11 | 2013 | 34 | |
| 12 | 2013 | 33 | |
| 13 | 2020 | 31 | |
| 14 | 2008 | 30 | |
| 15 | 2016 | 28 | |
| 16 | 2014 | 28 | |
| 17 | 2008 | 25 | |
| 18 | 2018 | 23 | |
| 19 | 2014 | 23 | |
| 20 | 2010 | 23 |
About Stefan Stremitzer
Stefan Stremitzer is a scholar working on Oncology, Surgery, Hepatology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 76 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Colorectal Cancer Treatments and Studies (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Genetic factors in colorectal cancer (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Gastric Cancer Management and Outcomes (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Hepatology (289 citations), Oncology (563 citations), Occupational Therapy (55 citations), Rehabilitation (75 citations) and Cancer Research (156 citations). Stefan Stremitzer has collaborated with scholars based in Austria, United States and Japan. Frequent co-authors include Thomas Gruenberger, Michael Bergmann, Dietmar Tamandl, Judith Stift, Thomas Hoelzenbein, Heinz‐Josef Lenz, Sebastian Stintzing, Martina Mittlboeck, Dongyun Yang and Thomas Wild. Their work appears in journals such as Journal of Clinical Oncology, The Pharmacogenomics Journal, European Journal of Surgical Oncology, Annals of Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.